Empowered Patient Podcast

Arya Massarat, Harvey Mudd College Class of 2020 graduated with Bachelor of Science degree in mathematical and computational biology and is continuing his studies at the University of California San Diego in the PhD program in bioinformatics and system biology. Arya talks about the reasons he has chosen to become a scientist, the value of his internship at the Salk Institute, and the need for an interdisciplinary approach combining math, computer science and biology to manage and make sense of the vast amount of biological data that is being generated.

@HarveyMudd @SalkInstitute @UCSDBiosciences

Listen to the podcast here

Arya Massarat, Harvey Mudd College Class of 2020 graduated with Bachelor of Science degree in mathematical and computational biology and is continuing his studies at the University of California San Diego in the PhD program in bioinformatics and system biology. Arya talks about the reasons he has chosen to become a scientist, the value of his internship at the Salk Institute, and the need for an interdisciplinary approach combining math, computer science and biology to manage and make sense of the vast amount of biological data that is being generated.

@HarveyMudd @SalkInstitute @UCSDBiosciences

Download the transcript here

Rhonda Collins, DNP, RN, FAAN and Chief Nursing Officer, Vocera is deeply concerned about the mental anguish and physical burdens that COVID-19 has placed on nurses and other front-line healthcare workers. She talks about ways in which hospitals can ease the stress by providing contextual information that the healthcare worker can immediately act on, the need to use technology to help mitigate cognitive overload, and ways in which healthcare workers can build their own resilience to the additional challenges that COVID-19 has added to their daily lives.

@RhondaCNO @VoceraComm #cognitiveoverload #COVID19

Vocera.com

Listen to the podcast here

Rhonda Collins, DNP, RN, FAAN and Chief Nursing Officer, Vocera is deeply concerned about the mental anguish and physical burdens that COVID-19 has placed on nurses and other front-line healthcare workers. She talks about ways in which hospitals can ease the stress by providing contextual information that the healthcare worker can immediately act on, the need to use technology to help mitigate cognitive overload, and ways in which healthcare workers can build their own resilience to the additional challenges that COVID-19 has added to their daily lives.

@RhondaCNO @VoceraComm #cognitiveoverload #COVID19

Vocera.com

Download the transcript here

Sonny Hsiao, CEO, President, and Co-Founder Acepodia Biotech discusses how Acepodia is transforming the cell therapy landscape through a flexible and cost-effective platform that can be used to develop potent treatments for a broad range of indications. Sonny describes how they are applying this technology to enhance and energize immune cells with antibodies so that the immune cells can bind to tumor cells and overcome the challenges of treating solid tumors.

@acepodiainc

#CellTherapy #Antibody #AntibodyCellConjugation #CancerTherapy #CancerTreatment #oncology

Acepodia.com

Listen to the podcast here

Sonny Hsiao, CEO, President, and Co-Founder Acepodia Biotech discusses how Acepodia is transforming the cell therapy landscape through a flexible and cost-effective platform that can be used to develop potent treatments for a broad range of indications. Sonny describes how they are applying this technology to enhance and energize immune cells with antibodies so that the immune cells can bind to tumor cells and overcome the challenges of treating solid tumors.

@acepodiainc

#CellTherapy #Antibody #AntibodyCellConjugation #CancerTherapy #CancerTreatment #oncology

Acepodia.com

Download the transcript here

Eddie Sullivan, President, CEO, Co-Founder, SAb Biotherapeutics talks about their innovative technology to generate targeted highly potent immunotherapies on a large scale. SAb is producing fully human polyclonal antibodies targeted to COVID-19 without the need for convalescent plasma blood donations by using genetically engineered cattle which produce the fully human antibodies.

@SABBantibody

#COVID19 #immunotherapies #antibodies

SAbbiotherapeutics.com/covid-19

Listen to the podcast here

Eddie Sullivan, President, CEO, Co-Founder, SAb Biotherapeutics talks about their innovative technology to generate targeted highly potent immunotherapies on a large scale. SAb is producing fully human polyclonal antibodies targeted to COVID-19 without the need for convalescent plasma blood donations by using genetically engineered cattle which produce the fully human antibodies.

@SABBantibody

#COVID19 #immunotherapies #antibodies

SAbbiotherapeutics.com/covid-19

Download the transcript here

Dr. Laurence Cooper, CEO, Ziopharm Oncology points to earlier work in immunotherapy to explain the advances in cancer treatment that revolve around the genetic engineering of cells to control gene expression and manipulation of the DNA of cells such as T-cells to go after cancer cells. The next generation immunotherapy will allow cells and agents to adapt in real time to overcome resistance and empower T-cells to go after the cancer weak spots.

@ziopharm

#cancer #CancerResearch #Immunotherapy #oncology

Ziopharm.com

Listen to the podcast here

Dr. Laurence Cooper, CEO, Ziopharm Oncology points to earlier work in immunotherapy to explain the advances in cancer treatment that revolve around the genetic engineering of cells to control gene expression and manipulation of the DNA of cells such as T-cells to go after cancer cells. The next generation immunotherapy will allow cells and agents to adapt in real time to overcome resistance and empower T-cells to go after the cancer weak spots.

@ziopharm

#cancer #CancerResearch #Immunotherapy #oncology

Ziopharm.com

Download the transcript here